Alembic Pharma Q3 net up 38% to 234 cr
Drug firm Alembic Pharmaceuticals on Wednesday reported a 37.89 per cent rise in consolidated net profit to 234.19 crore for the quarter ended Dece22-01-2020
22-01-2020
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December, 2019
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2019. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2019. b) Standalone Unaudited Financial Results for the quarter and nine months period ended 31st December, 2019. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 2:15 p.m. We request you to kindly take the same on record.22-01-2020
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of Board Meeting
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2019. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2019. b) Standalone Unaudited Financial Results for the quarter and nine months period ended 31st December, 2019. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 2:15 p.m. We request you to kindly take the same on record.22-01-2020
USFDA inspects Alembic Pharma's Gujarat facility
USFDA issued a form 483 with two observations, the drug firm said in a filing to BSE.21-01-2020
ALEMBIC PHARMACEUTICALS LTD. - 533573 - USFDA Inspection At Alembic Pharmaceuticals API Facility At Karkhadi
We would like to inform that the US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from 13th January, 2020 to 17th January, 2020. This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations. We request you to kindly take the same on record.21-01-2020
Hot Stocks | Alembic Pharma, Siemens can give up to 15% returns in the next 3-4 weeks
The apt strategy to trade in such a market would be to play the range i.e. buy as close as possible to support and vice versa.20-01-2020
Alembic gets USFDA nod for capsules used to treat spasticity
Drug firm Alembic Pharmaceuticals on Wednesday said it has received final nod from the US health regulator for Tizanidine hydrochloride capsules, use15-01-2020
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Empagliflozin Tablets, 10 mg and 25 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.15-01-2020
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.15-01-2020
Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression
Drug firm Alembic Pharmaceuticals on Monday said it has received a final nod from US health regulator for Vilazodone Hydrochloride tablets used for t13-01-2020